Press Release – Psychic Ventures Ltd The year 2021 is set to become quite a year for the pharma companies leading the COVID-19 vaccine race, with significant revenues on the line. As some of the most significant players in the market, pharma giants Pfizer and Moderna are set for the …The year 2021 is set to become quite a year for the pharma companies leading the COVID-19 vaccine race, with significant revenues on the line. As some of the most significant players in the market, pharma giants Pfizer and Moderna are set for the lion’s share of 2021 vaccine sales.
According to data presented by Finaria.it, BioNTech-Pfizer and Moderna COVID-19 vaccines sales are expected to generate $14.7bn in revenue by 2023.
Share
The Decentralized Trials and Research Alliance (DTRA) recently launched to accelerate the broad adoption of patient-focused decentralized clinical trials and research.
It plans to unite stakeholders across the health spectrum to further policies, research practices and technology innovation for decentralized clinical trials.
The alliance is currently made up of more than 50 life sciences and healthcare organizations, including AstraZeneca, the U.S. Food and Drug Administration, Pfizer and others.
DTRA member organizations will help identify gaps in the space and provide expertise to advance best practices through education and communication. The alliance is currently accepting organizations on its website.
WHY THIS MATTERS